Drawing for DNA.I

USPTO serial 87690531

DNA.I

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
BRECKENFELD, WILLIAM G
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with DNA.I?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Chelsea E. Carbone

CHELSEA E. CARBONE WILSON SONSINI GOODRICH & ROSATI650 PAGE MILL ROADPALO ALTO, CA 94304-1050UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Computer software platform for managing health data and information; computer software platform for interpreting DNA test results and identifying key health risk factors via an algorithm that analyzes health metrics and informs users as to which diagnostics are most important; computer software for collecting and analyzing health metrics for tracking, monitoring and diagnostic purposesACTIVE—
042Providing a website featuring a subscription-based service for users to upload, track and manage their health records; providing temporary use of nondownloadable computer software based on an algorithm that interprets DNA test results in combination with other diagnostic tests and identifies key health risk factors; application service provider, namely, hosting, managing, developing, analyzing, and maintaining an application, software, and a website for the purpose of managing health data for use in informing health decisions; providing a secure, web-based service featuring technology that enables internet users to create, annotate, and maintain health-related dataACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jan 7, 2019MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 7, 2019ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 5, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 10, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 10, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 21, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 5, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 4, 2018DOCKASSIGNED TO EXAMINER—
Dec 1, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 22, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance